Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4171U | ISIN: US1140823089 | Ticker-Symbol:
NASDAQ
27.06.25 | 15:30
1,910 US-Dollar
+0,53 % +0,010
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ERNEXA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
ERNEXA THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur ERNEXA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiErnexa Therapeutics Inc.: Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development2
DiErnexa Therapeutics completes second closing of securities offering1
DiErnexa Therapeutics Inc.: Ernexa Therapeutics Secures $6 Million in Second Closing Under Securities Purchase Agreement1
12.06.Ernexa Therapeutics kündigt Aktienzusammenlegung im Verhältnis 1:15 an3
11.06.Ernexa Therapeutics registers 57M shares for resale2
11.06.Ernexa Therapeutics Inc. - S-8, Securities to be offered to employees in employee benefit plans1
10.06.Ernexa Announces 1-for-15 Reverse Stock Split Effective June 12 To Regain Nasdaq Compliance-
ERNEXA THERAPEUTICS Aktie jetzt für 0€ handeln
10.06.Ernexa Therapeutics announces 1-for-15 reverse stock split1
10.06.Ernexa Therapeutics Inc.: Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split167CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced...
► Artikel lesen
09.06.Ernexa Therapeutics Inc. - 8-K, Current Report2
02.06.Ernexa Therapeutics Inc. - 8-K, Current Report1
28.05.Ernexa Therapeutics Inc.: Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 20252
14.05.Ernexa Therapeutics Inc.: Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations118CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced...
► Artikel lesen
08.05.D.Boral Capital: Ernexa Therapeutics Announces Participation in the D. Boral Capital Inaugural Global Conference234Cambridge, Massachusetts--(Newsfile Corp. - May 8, 2025) - Ernexa Therapeutics (NASDAQ: ERNA), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May...
► Artikel lesen
07.05.Ernexa Therapeutics Inc. - 10-Q, Quarterly Report1
29.04.Ernexa reports promising cancer cell therapy study results2
22.04.Ernexa Therapeutics Inc.: Ernexa Therapeutics Announces New Data to be Presented at AACR Annual Meeting 20251
03.04.Ernexa Therapeutics Inc.: Ernexa Therapeutics Closes New Funding Round160CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced...
► Artikel lesen
03.04.Eterna Therapeutics Inc. - 8-K, Current Report5
25.03.Eterna Therapeutics Changes Name to Ernexa Therapeutics to Reflect New Strategic Focus on Ovarian Cancer and Autoimmune Disease120Ernexa Therapeutics embarks on new strategic direction, shifting the company's focus from delivering a cell therapy platform to prioritizing product development New tagline to emphasize the company's...
► Artikel lesen
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1